Selected research
Market Structure
Global Ticagrelor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ticagrelor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ticagrelor include Sun Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, Pfizer, Bayer, Astrazeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ticagrelor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ticagrelor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ticagrelor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ticagrelor market size, projected growth trends, production technologies, key applications, and end-use industries.
Ticagrelor Segment by Company
Sun Pharmaceutical
Johnson & Johnson
Merck
Eli Lilly
Pfizer
Bayer
Astrazeneca
Boehringer Ingelheim
Ticagrelor Segment by Type
90 mg Tablet
60 mg Tablet
Ticagrelor Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Ticagrelor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ticagrelor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ticagrelor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ticagrelor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ticagrelor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ticagrelor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ticagrelor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ticagrelor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 90 mg Tablet
- 60 mg Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- Bayer
- Astrazeneca
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ticagrelor Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ticagrelor Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ticagrelor Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ticagrelor Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ticagrelor Market Dynamics
- 2.1 Ticagrelor Industry Trends
- 2.2 Ticagrelor Industry Drivers
- 2.3 Ticagrelor Industry Opportunities and Challenges
- 2.4 Ticagrelor Industry Restraints
3 Ticagrelor Market by Manufacturers
- 3.1 Global Ticagrelor Revenue by Manufacturers (2021-2026)
- 3.2 Global Ticagrelor Sales by Manufacturers (2021-2026)
- 3.3 Global Ticagrelor Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ticagrelor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ticagrelor Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ticagrelor Manufacturers, Product Type & Application
- 3.7 Global Ticagrelor Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ticagrelor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ticagrelor Players Market Share by Revenue in 2025
- 3.8.3 2025 Ticagrelor Tier 1, Tier 2, and Tier 3
4 Ticagrelor Market by Type
- 4.1 Ticagrelor Type Introduction
- 4.1.1 90 mg Tablet
- 4.1.2 60 mg Tablet
- 4.2 Global Ticagrelor Sales by Type
- 4.2.1 Global Ticagrelor Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ticagrelor Sales by Type (2021-2032)
- 4.2.3 Global Ticagrelor Sales Market Share by Type (2021-2032)
- 4.3 Global Ticagrelor Revenue by Type
- 4.3.1 Global Ticagrelor Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ticagrelor Revenue by Type (2021-2032)
- 4.3.3 Global Ticagrelor Revenue Market Share by Type (2021-2032)
5 Ticagrelor Market by Application
- 5.1 Ticagrelor Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Ticagrelor Sales by Application
- 5.2.1 Global Ticagrelor Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ticagrelor Sales by Application (2021-2032)
- 5.2.3 Global Ticagrelor Sales Market Share by Application (2021-2032)
- 5.3 Global Ticagrelor Revenue by Application
- 5.3.1 Global Ticagrelor Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ticagrelor Revenue by Application (2021-2032)
- 5.3.3 Global Ticagrelor Revenue Market Share by Application (2021-2032)
6 Global Ticagrelor Sales by Region
- 6.1 Global Ticagrelor Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ticagrelor Sales by Region (2021-2032)
- 6.2.1 Global Ticagrelor Sales by Region (2021-2026)
- 6.2.2 Global Ticagrelor Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ticagrelor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ticagrelor Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ticagrelor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ticagrelor Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ticagrelor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ticagrelor Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ticagrelor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ticagrelor Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ticagrelor Revenue by Region
- 7.1 Global Ticagrelor Revenue by Region
- 7.1.1 Global Ticagrelor Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ticagrelor Revenue by Region (2021-2026)
- 7.1.3 Global Ticagrelor Revenue by Region (2027-2032)
- 7.1.4 Global Ticagrelor Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ticagrelor Revenue (2021-2032)
- 7.2.2 North America Ticagrelor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ticagrelor Revenue (2021-2032)
- 7.3.2 Europe Ticagrelor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ticagrelor Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ticagrelor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ticagrelor Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ticagrelor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical
- 8.1.1 Sun Pharmaceutical Company Information
- 8.1.2 Sun Pharmaceutical Business Overview
- 8.1.3 Sun Pharmaceutical Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Ticagrelor Product Portfolio
- 8.1.5 Sun Pharmaceutical Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Ticagrelor Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Ticagrelor Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Eli Lilly
- 8.4.1 Eli Lilly Company Information
- 8.4.2 Eli Lilly Business Overview
- 8.4.3 Eli Lilly Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Eli Lilly Ticagrelor Product Portfolio
- 8.4.5 Eli Lilly Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Ticagrelor Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Bayer
- 8.6.1 Bayer Company Information
- 8.6.2 Bayer Business Overview
- 8.6.3 Bayer Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Bayer Ticagrelor Product Portfolio
- 8.6.5 Bayer Recent Developments
- 8.7 Astrazeneca
- 8.7.1 Astrazeneca Company Information
- 8.7.2 Astrazeneca Business Overview
- 8.7.3 Astrazeneca Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Astrazeneca Ticagrelor Product Portfolio
- 8.7.5 Astrazeneca Recent Developments
- 8.8 Boehringer Ingelheim
- 8.8.1 Boehringer Ingelheim Company Information
- 8.8.2 Boehringer Ingelheim Business Overview
- 8.8.3 Boehringer Ingelheim Ticagrelor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Boehringer Ingelheim Ticagrelor Product Portfolio
- 8.8.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ticagrelor Value Chain Analysis
- 9.1.1 Ticagrelor Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ticagrelor Production Mode & Process
- 9.2 Ticagrelor Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ticagrelor Distributors
- 9.2.3 Ticagrelor Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst